Skip to main content
Erschienen in: Journal of Echocardiography 4/2012

01.12.2012 | Images in Cardiovascular Ultrasound

A rare case of cardiac myxoma from the left atrial appendage presenting with acute myocardial infarction

verfasst von: Kuntal Bhattacharya, Harsh Wardhan, Neeraj Pandit, Ranjit K. Nath

Erschienen in: Journal of Echocardiography | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Excerpt

A 35-year-old man presented to the emergency department with acute-onset chest pain and cold sweating. His electrocardiogram was suggestive of anterior wall ST segment elevation myocardial infarction (STEMI). Clinical examination and cardiac auscultation did not show any abnormality. He was thrombolysed successfully with streptokinase. He had no known risk factors for coronary artery disease (CAD). Transthoracic echocardiogram was suggestive of mild hypokinesia of the left anterior descending artery (LAD) territory with preserved left ventricular (LV) systolic function. Strikingly, a thin, highly mobile echogenic mass mimicking vegetation was found near mitral leaflets (Fig. 1) and the left atrial appendage appeared hazy in transthoracic echocardiography. The origin and type of the mass cannot be specified in transthoracic echocardiography. Transesophageal echocardiogram was performed, which showed clearly the same mass arising from the left atrial appendage attached with a stalk, measuring 5.5 cm × 0.6 cm (Fig. 2). It was attached at the left atrial appendage and the rest of the mass is thin, long and highly mobile, and was prolapsing in the LV cavity in diastole through mitral inflow. The commonest mass in the left atrium is a thrombus. But this is unlikely in our case. We suspected this mass as myxoma or fibroelastoma. Coronary angiogram was performed on the third day and showed clean coronaries, probably because of thrombolysis of embolus, which are most often thrombus forming over the surface of myxoma than tumour embolus. The patient was advised surgical excision of that mass. The macroscopic and histopathology examination confirmed the nature of the mass as myxoma. Systemic embolisation including coronary arteries is reported from the left atrial myxoma [1]. The presence of any mass other than thrombus is extremely rare in the left atrial appendage. There are very few case reports describing myxoma causing coronary embolism and myocardial infarction [13] or arising from the left atrial appendage [4, 5]. We have reported the first case of left atrial appendage myxoma causing coronary embolism and myocardial infarction. In our case, the shape of the myxoma is very atypical, along with its site of origin and presentation. This case also showed the importance of transesophageal echocardiography over transthoracic echocardiography to delineate the left atrial appendage pathology.
Literatur
1.
Zurück zum Zitat Rath S, Har-Zahav Y, Battler A, et al. Coronary arterial embolus from left atrial myxoma. Am J Cardiol. 1984;54:1392–3.PubMedCrossRef Rath S, Har-Zahav Y, Battler A, et al. Coronary arterial embolus from left atrial myxoma. Am J Cardiol. 1984;54:1392–3.PubMedCrossRef
2.
Zurück zum Zitat Isomatsu Y, Nishiya Y, Hoshino S, et al. Left atrial myxoma associated with acute myocardial infarction. Jpn J Thorac Cardiovasc Surg. 1999;47(9):452–4.PubMedCrossRef Isomatsu Y, Nishiya Y, Hoshino S, et al. Left atrial myxoma associated with acute myocardial infarction. Jpn J Thorac Cardiovasc Surg. 1999;47(9):452–4.PubMedCrossRef
3.
Zurück zum Zitat Yavuz T, Peker O, Ocal A, et al. Left atrial myxoma associated with acute myocardial infarction. Int J Cardiovasc Imaging. 2005;21(2–3):235–8.PubMedCrossRef Yavuz T, Peker O, Ocal A, et al. Left atrial myxoma associated with acute myocardial infarction. Int J Cardiovasc Imaging. 2005;21(2–3):235–8.PubMedCrossRef
4.
Zurück zum Zitat Livi U, Bortolotti U, Milano A, et al. Cardiac myxomas: results of 14 years’ experience. Thorac Cardiovasc Surg. 1984;32:143–7.PubMedCrossRef Livi U, Bortolotti U, Milano A, et al. Cardiac myxomas: results of 14 years’ experience. Thorac Cardiovasc Surg. 1984;32:143–7.PubMedCrossRef
5.
Zurück zum Zitat Turhan S, Kilickap M, Candemir B, et al. Three unusual myxomas originating from the left atrial appendage: a case report. J Am Soc Echocardiogr. 2005;18(6):694.PubMed Turhan S, Kilickap M, Candemir B, et al. Three unusual myxomas originating from the left atrial appendage: a case report. J Am Soc Echocardiogr. 2005;18(6):694.PubMed
Metadaten
Titel
A rare case of cardiac myxoma from the left atrial appendage presenting with acute myocardial infarction
verfasst von
Kuntal Bhattacharya
Harsh Wardhan
Neeraj Pandit
Ranjit K. Nath
Publikationsdatum
01.12.2012
Verlag
Springer Japan
Erschienen in
Journal of Echocardiography / Ausgabe 4/2012
Print ISSN: 1349-0222
Elektronische ISSN: 1880-344X
DOI
https://doi.org/10.1007/s12574-012-0146-9

Weitere Artikel der Ausgabe 4/2012

Journal of Echocardiography 4/2012 Zur Ausgabe

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

LDL-Cholesterin kann ApoB als Risikomarker nicht ersetzen

16.05.2024 Hypercholesterinämie Nachrichten

Apolipoprotein B (ApoB) ist ein genauer Risikomarker für atherosklerotisch bedingte Erkrankungen. Aber das LDL-Cholesterin doch auch – lohnt sich also die ApoB-Messung überhaupt?

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.